ATNX Athenex Inc.

Athenex Inc is a global biopharmaceutical company dedicated to the discovery, development and commercialization of novel therapies for the treatment of cancer.

$4.48  -0.34 (-7.06%)
As of 03/04/2021 15:59:59 EST     IEX book   CBOE book


Security Information
Category1:
Category2:
Category3:
GICS sector:
Industry:
Index country:
Country of incorporation:
IPO date:
Outstanding shares:
Average volume:
Market cap:
Current dividend yield:
All SEC filings:
Quarterly filings:
Annual filings:
CUSIP:
ISIN:
Sedol:
US Equity
Common stocks
Small cap
Health Care
Drug Manufacturers—Specialty &
USA
USA
06/14/2017
93,454,700
4,728,954
$449,984,381
0.00%
SEC Edgar Online
10-Q
10-K
04685N103
US04685N1037
BF04FC3

Valuation   (See tab for details)
PE ratio:
PB ratio:
PS ratio:
Return on equity:
Net income %:
-3.08
2.50
3.12
-64.75%
-101.24%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy